Dunelm Group (LON:DNLM) and InnovaDerma (LON:IDP) are both consumer cyclical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, dividends, earnings, valuation and risk.
Analyst Recommendations
This is a breakdown of current recommendations and price targets for Dunelm Group and InnovaDerma, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Dunelm Group | 2 | 3 | 2 | 0 | 2.00 |
InnovaDerma | 0 | 0 | 0 | 0 | N/A |
Dunelm Group currently has a consensus price target of GBX 1,168, indicating a potential downside of 19.23%. Given Dunelm Group's higher possible upside, equities analysts plainly believe Dunelm Group is more favorable than InnovaDerma.
Valuation & Earnings
This table compares Dunelm Group and InnovaDerma's revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Dunelm Group | £1.19 billion | 2.46 | N/A | GBX 53.80 | 26.88 |
InnovaDerma | £12.28 million | 0.59 | N/A | GBX (7.10) | -5.89 |
InnovaDerma is trading at a lower price-to-earnings ratio than Dunelm Group, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares Dunelm Group and InnovaDerma's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Dunelm Group | N/A | N/A | N/A |
InnovaDerma | N/A | N/A | N/A |
Summary
Dunelm Group beats InnovaDerma on 6 of the 6 factors compared between the two stocks.